Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vacuolar protein sorting-associated protein 54 (VPS54) is a subunit of the Golgi-associated retrograde protein (GARP) complex, which is a multisubunit tethering factor essential for retrograde trafficking of vesicles from both early and late endosomes to the trans-Golgi network[1][4]. VPS54 is required for proper protein sorting within the endomembrane system, impacting retrieval of specific SNAREs and receptors in the cell. Structurally, VPS54 contains distinct N-terminal and C-terminal domains, with the N-terminus critical for complex assembly and the C-terminus involved in organelle localization and retrograde transport function. Mutations in this protein, especially within the C-terminal domain (e.g., L967Q), are associated with neurodegenerative phenotypes, particularly in mouse models of spinal muscular atrophy similar to ALS[2]. It is not currently considered a direct therapeutic target such as an enzyme, transporter, or receptor, but is of interest in the study of vesicle trafficking, neurodegeneration, and possibly certain cancers[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar protein sorting-associated protein 54 (VPS54).